Following myomectomy the rate of fertility is restored and
pregnancy may be attempted with a good outcome. In the present
study a 3 month treatment with OCs in a group of women after a
myomectomy was evaluated. The drug compliance and side effects,
the benefits of OC in order to reduce symptoms, to increase
post-surgical hemoglobin levels and to avoid an early pregnancy
after myomectomy were analyzed. A group of women (n = 55) each with myoma ≥5 cm was recruited: they presented menorrhagia,
pelvic pain, dyspareunia and dysmenorrhae. After laparotomic
myomectomy the women were divided into 3 groups. Group 1: women
(n = 16) treated with pill A (15 mcg of
ethynilestradiol + 60 mcg of gestodene); group 2: women
(n = 23) treated with pill B (20 mcg of
ethynilestradiol + 100 mcg of levonorgestrel); group 3:
women (n = 16) treated with a placebo (oral calcium). After three
months from myomectomy and treatment patients in each group
reported a reduced menorrhagia, dismenorrhea and pelvic pain.
Serum haemoglobin levels increased in all women (P < .05). No pregnancy occurred in any group and the
compliance was good. A post surgery treatment by using oral
contraceptives guarentees pregnancy prevention, associated with
reduction of pain, and improvement of haematologic conditions.